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Transfusional iron overload in patients with sickle cell
anemia: comparison between magnetic resonance imaging
and serum ferritin*
Sobrecarga de ferro transfusional em portadores de anemia falciforme: comparação entre ressonância
magnética e ferritina sérica
Lécio dos Anjos Bourbon Filho1, Thiago de Oliveira Ferrão2, Alex Vianey Callado França3, Ricardo
Dantas Rocha1, Lorena Dias Dantas1, Luciana Franco do Prado Carvalho1, Marcella Dornelas
de Abreu Batalha Moreira1, Rosana Cipolotti4
Objective: To identify predictive variables of iron overload in patients with sickle cell anemia, correlating biochemical
and imaging markers. Materials and Methods: The authors developed a cross-sectional study involving 32 patients
with sickle cell anemia who were evaluated for ferritin and iron serum levels and submitted to liver magnetic resonance
imaging with one spin-echo and five gradient-echo sequences. The signal intensity was obtained at each sequence,
corresponding to the arithmetical mean of the measurements on regions of interest in the liver and paraspinal muscles
to obtain the liver/muscle signal intensity ratio (SIR). Based on such SIR, the liver iron concentration (LIC) was estimated
by means of the following formula: e[5.808 – (0.877 × T2*) – (1.518 × IW)], where T2* is the SIR on the sequence with echo time
= 13 ms and IW is the SIR on the intermediate-weighted sequence. Patients were grouped according to their blood
transfusion regimen (regular monthly versus sporadic transfusions). Results: The comparison between the transfusion
groups was based on clinical-laboratory variables, with significant differences in SIR, LIC and serum ferritin levels: the
group with regular transfusions demonstrated greater hepatic iron overload. Conclusion: Magnetic resonance imaging
is an efficient tool for evaluating liver iron overload in patients with sickle cell anemia.
Keywords: Sickle cell anemia; Magnetic resonance imaging; Ferritin.
Objetivo: Identificar variáveis preditoras de sobrecarga de ferro em portadores de anemia falciforme e correlacionar
indicadores bioquímicos e imaginológicos. Materiais e Métodos: Foi realizado estudo transversal envolvendo 32
portadores de anemia falciforme, que foram submetidos a dosagem sérica de ferro, ferritina e a ressonância magné-
tica do fígado. Foram realizadas cinco sequências gradiente-eco e uma spin-eco. A intensidade de sinal foi obtida em
cada sequência pelas médias das regiões de interesse no fígado e musculatura paravertebral para obter a razão da
intensidade de sinal (RIS) fígado/músculo. A partir da RIS foi obtida a concentração hepática estimada de ferro (CHEF)
pela fórmula: e[5,808 – (0,877 × T2*) – (1,518 × PI)], onde T2* é a RIS na sequência com TE de 13 ms e PI é a RIS da sequência
com ponderação intermediária. Os pacientes foram agrupados segundo o regime de transfusão de hemácias (regula-
res mensais versus esporádicas). Resultados: Os grupos transfusionais foram comparados pelas variáveis clínico-
laboratoriais, sendo significativas as diferenças entre RIS, CHEF e ferritina sérica: o grupo que recebeu transfusões
regulares apresentou sobrecarga de ferro hepático mais intensa. Conclusão: A ressonância magnética foi ferramenta
eficiente para avaliação de sobrecarga hepática de ferro em portadores de anemia falciforme.
Unitermos: Anemia falciforme; Imagem por ressonância magnética; Ferritina.
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INTRODUCTION
In the setting of acute complications of
sickle cell anemia (SCA), the decrease in
hemoglobin levels may precipitate a
ORIGINAL ARTICLE
cardio-pulmonary function decompensa-
tion, so erythrocytes transfusion become a
therapeutic resource of great importance(1).
With the frequent long term utilization of
such resource, some complications such as
iron overload may occur(2), as there is no
active excretory mechanism for this micro-
nutrient. Main manifestations of advanced
iron overload include dysfunction of or-
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gans such as the liver, heart and endocrine
organs.
There are direct and indirect methods to
estimate body iron levels(3). Serum ferritin
test is the most available method and is
easily reproducible, in spite of not provid-
ing a good specificity(3). Hepatic biopsy, in
spite of being validated as a reference stan-
dard, is an invasive method and, therefore,
involves risks inherent to the procedure(4).
For these reasons, the possibility of replac-
ing such a procedure by a noninvasive im-
aging method, in this case magnetic reso-
nance imaging (MRI), is discussed(5).
Several studies have described the uti-
lization of MRI in the quantification of
hepatic iron content, with variable results
among them(5–9). Iron overload causes a
decrease in the signal intensity of the he-
patic parenchyma and the measurement of
such an overload is possible since there is
a correlation between the magnitude of sig-
nal reduction and the degree of iron ex-
cess(8).
The present study is aimed at estimat-
ing the liver iron concentration by means
of MRI in patients with SCA, and correlat-
ing iron overload biochemical and imaging
markers in two different transfusion regi-
mens.
MATERIALS AND METHODS
A cross-sectional study was developed
with SCA patients regularly followed-up at
a reference outpatient clinic in the state of
Sergipe, Northeastern region of Brazil. In
this region, there is a high prevalence of the
hemoglobin S gene because of the ethnic
composition of the population(10). For the
purposes of the present study, eligible pa-
tients were those with SCA confirmed by
means of hemoglobin electrophoresis and
had already undergone blood transfusion.
Patients with chronic hepatic disease not
related to SCA were excluded.
Thirty-two patients were sequentially
selected and divided into two groups: the
first group comprised patients undergoing
sporadic blood transfusions due to compli-
cations (SG), and the second group, com-
prising patients undergoing regular blood
transfusions (RG): 10 to 20 ml/kg admin-
istered monthly because their history of
cerebrovascular accident.
All the patients underwent clinical ex-
amination, laboratory tests (serum ferritin,
serum iron, aminotransferase test and
blood count) and MRI. Upper abdomen
MRI scans were performed in a 1.5T
Magnetom Avanto (Siemens; Munich,
Germany) apparatus, without the use of
contrast medium or sedation.
The parameters utilized for the se-
quences acquisition were based on the pro-
tocol proposed by Alústiza et al.(8). The
technique comprised five breath-hold GRE
sequences (20 sections each), and one TSE
trigger sequence (with respiratory synchro-
nization and 35 sections), whose details are
described on Table 1.
All the images were analyzed by a
single experienced and duly trained radi-
ologist. The regions of interest (ROIs),
measuring at least 1 cm2, were positioned
on three areas of the right hepatic lobe for
measurement of the signal intensity and on
two areas of the paravertebral musculature,
one at right and the other at left, distant
from the lung bases, hepatic vessels and
from heterogeneous areas, in order to avoid
artifacts. The arithmetic means of the three
hepatic measurements and two muscular
measurements were obtained, and the ratio
between means was calculated, corre-
sponding to the signal intensity ratio (SIR).
The SIR was utilized, instead of the signal
intensity in the liver alone, as the SIR con-
siders the usual decrease in signal intensity
that normally occurs as the echo time
elapses, and because of the need for a ref-
erence tissue, the paravertebral muscula-
ture, that usually does not undergo iron
deposition. Based on the SIR, the estimated
hepatic iron concentration (EHIC) was
obtained by means of the formula:
e[5.808 – (0.877 × T2*) – (1.518 × PI)]
where T2* is the SIR obtained on the se-
quence with TE = 14 ms, and PI is the SIR
of the intermediate-weighted sequence.
A previous study indicates that such
formula shows excellent correlation be-
tween SIR and hepatic iron concentration
measured in hepatic tissue obtained by
means of biopsy (r = 0.937)(8).
Means and standard deviations for
quantitative variables and frequency distri-
bution for proportional variables were uti-
lized for data analysis. The patients were
grouped according to two EHIC cut-off
points and according to transfusional group
(either SG or RG); the results were cross
checked and compared with each other and
between the groups. The groups compari-
son was made by means of the chi-square
or Fisher’s tests (proportional variables and
discrete quantitative variables) and by
means of the t test for independent samples
or the Kruskal-Wallis test (continuous
quantitative variables), considering 5% (p
< 0.05) as significance level. The correla-
tions between SIR and serum iron and se-
rum ferritin levels were evaluated by means
of the Pearson correlation coefficient (r).
The project of the present study was
duly submitted and approved by the Com-
mittee for Ethics in Research of the respon-
sible institution (CAE 0013.0.107.000-09),
and the consent of the patients or parents/
caregivers were expressed by means of the
signature of a term of free and informed
consent.
RESULTS
Thirty-two patients were submitted to
MRI and had their serum ferritin levels
measured. Among these patients, 23
(71.87%) were sporadically submitted to
blood transfusion (SG).
Table 1 MRI sequences parameters†.
Sequence
GE T1-weighted
GE IW
GE T2*-weighted
GE T2*-weighted
GE T2*-weighted
TSE T2-weighted
TE (ms)
4
4
9
14‡
21
82
TR (ms)
120
120
120
120
120
3650
SL (mm)
7
7
7
7
7
5
FA
90°
20°
20°
20°
20°
—
FOV
370
370
370
370
370
380
† According to Alústiza et al.(8). ‡ TE was modified from 14 ms to 13 ms, considering results obtained in a pilot-
study. TE, echo time; TR, repetition time; SL, slice thickness; FA, flip angle; FOV, field of view; GE, gradient-echo;
IW, intermediate weighting; TSE, turbo spin-echo.
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There was a subtle predominance of the
male gender, with 19/32 patients (59.37%).
The mean patients’ age was 14.21 ± 5.46
years. The mean serum ferritin value was
1,124.34 ± 644.26 µg/l, and serum iron
value was 123.94 ± 45.12 µg/dl. The mean
values for alanine transaminase and aspar-
tate transaminase were 35.62 ± 27.82 U/l
and 46.65 ± 23.12 U/l, respectively. The
mean annual hemoglobin level was 8.20 ±
1.24 g/dl, and the total leukocyte count had
a mean value of 12,009 ± 3,764/mm3 and
platelets, 370,853 ± 134,101/mm3.
The patients were stratified according to
iron overload (according to EHIC calcu-
lated from the MRI results) at two cut-off
points – 40 µmol/g and 80 µmol/g – and the
clinical and laboratory predictors of iron
overload were evaluated. Figure 1 shows
liver MR images of a patient with EHIC of
20.7 µmol/g (A) and 262.2 µmol/g (B).
Serum ferritin levels presented a mean
value 58% higher in the group with iron
overload, as 40 µmol/g was utilized as cut-
off point, and 50% higher as the cut-off was
80 µmol/g, with statistically significant
differences in both cases (p = 0.0001 and
Table 2 General patients’ characteristics according to estimated hepatic iron concentration, demon-
strated with two cut-off points.
EHIC (µmol/g)
Age
Male
AST (U/l)
ALT (U/l)
Hb (g/dl)
Leuko (/mm3)
Plat (/mm3)
Iron (µg/dl)
Ferritin (µg/dl)
SG
RG
> 40
14.42
63 (12/19)
45.94
39.31
8.41
12,257
400,015
121.20
1,477.49
52 (10/19)
48 (9/19)
< 40
13.9
38.4 (5/13)
47.21
29.50
7.90
11,932
329,678
127.73
608.20
100 (13/13)
0 (0/134)
p
0.8229
0.1766
0.8734
0.4515
0.2280
0.3721
0.1451
0.6959
0.0001
0.0032
> 80
15.2
57 (8/14)
46.5
41.21
8.31
12,014
378,378
128.44
1,560.07
50 (7.14)
50 (7/14)
< 80
13.3
50 (9/18)
46.7
31.27
8.12
12,005
365,000
120.24
785.44
88.8 (16/18)
11.2 (2/18)
p
0.3047
0.4681
0.9928
0.7812
0.5857
0.7947
0.7619
0.6203
0.0002
0.0234
EHIC, estimated hepatic iron concentration; AST, aspartate transaminase; ALT, alanine transaminase; Hb, annual
mean hemoglobin; Leuko, annual mean leukogram; Plat, annual mean platelets; SG, sporadic transfusional
group; RG, regular transfusional group.
Table 3 MRI sequences weighting and their relationship with two groups (serum ferritin and serum iron).
Signal intensity
T1†
IW‡
T2* 9 ms§
T2* 13 ms§
T2* 21 ms§
Ferritin (µg/dl) Iron (µg/dl)
> 1.000
0.7233
0.6433
0.3795
0.2971
0.2024
< 1.000
1.2145
1.0818
0.9509
0.9009
0.7309
p
0.0017
0.0005
0.0002
0.0001
0.0002
> 500
0.7952
0.7036
0.4472
0.3556
0.2332
< 500
1.2386
1.1171
1.0357
1.0371
0.9229
p
0.0062
0.0014
0.0008
0.0001
0.0001
> 150
0.8729
0.7486
0.5729
0.4714
0.3386
< 150
0.9188
0.8025
0.5929
0.5304
0.4075
p
0.8082
0.7618
0.9111
0.7448
0.6752
† T1-weighted sequence; ‡ intermediate weighted sequence; § gradient-echo sequences T2-weighted sequences with echo times of 9 ms, 13 ms and 21ms, respectively.
p = 0.0002, respectively). The “transfu-
sional group” variable demonstrated to be
predictive for overload, such an overload
being greater in the group receiving regu-
lar transfusions (p = 0.0032 and p = 0.0234,
respectively, for the EHIC cut-off points at
40 µmol/g and 80 µmol/g). The other vari-
ables did not present statistical significance
(Table 2).
The correlation between the means of
signal intensity ratios obtained from MRI
and serum ferritin levels results, utilizing
two reference groups as parameter (1,000
mg/dl and 500 mg/dl), was calculated and
is shown on Table 3. It is observed that all
the MRI sequences present lower signal
intensity in the group with higher ferritin
levels, for both cut-off points, a statistically
significant result. Such a fact was not ob-
served in cases where serum iron level was
utilized as a reference.
The comparison of transfusional groups
was based on the clinical and laboratory
variables. The values that presented statis-
tical difference were SIR of the MRIs,
EHIC and serum ferritin level. The remain-
ing clinical and laboratory variables did not
present any statistically significant differ-
ence (Table 4).
Figure 1. Abdominal MRI T2-weighted sequence* (TE = 13 ms). A: Patient with EHIC of 20.7 µmol/g. B:
Patient with EHIC of 262.2 µmol/g. The noticeable difference in signal intensity between both livers is
observed.
A B
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which are currently utilized for such pur-
pose: serum ferritin test and MRI. The cut-
off point for serum ferritin levels from
which one can consider that tissue damage
has already occurred is still to be deter-
mined: certainly, in cases where the values
are > 1.000 mg/dl, the damages to organs
and tissues have already occurred and some
authors defend that the utilization of chelat-
ing agents be started at levels < 500 mg/
dl(3). In individuals with no risk factors for
iron overload, it is expected the EHIC are
below 20 µmol/g. For those with chronic
hemolytic anemia, tissue damage seems to
occur between 40 µmol/g and 80 µmol/g(4,5).
According to a previous study, serum
ferritin levels do not present good correla-
tion with the hepatic iron concentration(11).
However, other sources indicate a linear
correlation between serum ferritin levels
and total estimated body iron by means of
the evaluation of tissue iron concentration
in liver biopsy specimen(3,9,12). However, it
is known that the quantification of serum
ferritin may be influenced by a number of
factors, such as gender, infections, hepato-
pathies and cancer(3,13,14). For that reason,
its serial measurement is more accurate
than the isolated measurement(13,14).
Angulo et al.(13) have not demonstrated
linear relationship between mean serum
ferritin levels in four years and the EHIC
obtained by MRI, a finding that is in agree-
ment with the present study.
Based on the present results, it is pos-
sible to observe that the only clinical and
laboratory predictive variables for transfu-
sion iron overload are serum ferritin levels
and transfusional group, which is in agree-
ment with reports in the literature(3,12).
Hepatic enzymes did not demonstrate to be
a good iron overload indicator, which has
already been previously observed(12). In the
present study, no other variable could be
utilized as an iron overload predictor, in-
dependently from the utilized cut-off point.
It is important to highlight that the liver
is the main iron storage organ, and the first
to be injured, however the lesion of other
organs, such as kidneys, pancreas, lungs,
endocrine glands and heart, may decisively
contribute to the death of patients with
SCA(3,12,13,15,16).
The long term effects of chronic iron
overload have been more extensively de-
Figure 2. Correlation between EHIC and serum ferritin and iron levels. A: Correlation between serum
ferritin levels and EHIC (r = 0.44). B: Correlation between serum iron levels and EHIC (r = 0.01).
Table 4 Comparison among individuals in the group undergoing sporadic transfusions and individuals
in the group with regular transfusions, according to all the studied variables.
EHIC (µmol/g)
T1
IW
T2* 9 ms
T2* 13 ms
T2* 21 ms
Ferritin (µg/l)
Iron (µg/dl)
AST (U/l)
ALT (U/l)
Leukogram (mean/year)
Hemoglobin (mean/year)
Platelets (mean/year)
Age
Male patients
Female patients
SG
62.5176
1.0544
0.9552
0.7196
0.6384
0.4844
962.78
129.05
44.0
29.69
12,237.08
8.22
369,625.00
14.26
43.5% (10/23)
56.5% (13/23)
RG
196.1711
0.4400
0.3733
0.2078
0.1422
0.1211
1,537.22
111.46
53.44
50,77
11,466.66
8.21
391,033.33
14.11
77.8% (7/9)
22.2% (2/9)
p
0.0001
0.0001
0.0001
0.0006
0.0006
0.0105
0.0249
0.3297
0.4941
0.1596
0.6047
0.9067
0.6059
0.7548
0.1242
SG, sporadic transfusional group; RG, regular transfusional group; EHIC, estimated hepatic iron concentration;
T1, signal intensity ratio (SIR) of T1-weighted sequence; IW, SIR of the intermediate weighted sequence; T2*,
SIR of the gradient-echo sequences T2*-weighted with echo times of 9 ms, 13 ms and 21 ms, respectively; AST,
aspartate transaminase; ALT, alanine transaminase.
Figure 2 represents the correlations be-
tween EHIC and serum ferritin (A) and iron
(B) levels. Serum ferritin levels did not
present good linear correlation with EHIC,
with a Pearson correlation coefficient equal
to 0.44. The correlation with serum iron
level was even worse than that of serum
ferritin level (r = 0.01).
DISCUSSION
An accurate and reproducible method
for detection, evaluation and stratification
of transfusion iron overload is a very use-
ful tool in the clinical follow-up of patients
with hemolytic anemia. The present study
compared, in SCA patients, two strategies
A B
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scribed in patients with thalassemia, and
SCA particularities may not allow the
simple transfer of findings, among them the
persistent activation of the inflammatory
response cascade, as it modifies the serum
ferritin concentration. Thus, in SCA pa-
tients, such variable is not a good indica-
tor of iron overload in the organs. On the
other hand, the serial imaging evaluation of
a sentinel organ – the liver – may yield
more reproducible data.
By comparing the iron-overload inten-
sity between the patient groups submitted
to two different transfusion regimens, it is
possible to conclude that the group under-
going regular transfusions is more subject
to the overload complications as, on aver-
age, such group presents three times the
EHIC as compared with the group under-
going sporadic transfusions. Such result is
in agreement with data in the literature, as
the number of transfusions is already a well
established predictive factor for iron over-
load(3,12). The other variables that are pre-
dictive of overload (signal intensity and
serum ferritin levels) were also altered in
that group. Therefore, the RG patients must
be closely followed-up particularly for the
diagnosis and treatment of transfusional
iron overload.
The categorization of patients according
to the transfusional profile and the confir-
mation that the group under regular trans-
fusions presents more consistent signs of
hepatic iron overload is justified because
indicates a group of patients as priority
candidates for MRI evaluation as soon as
they receive the indication and start receiv-
ing regular transfusions. The periodicity of
such evaluation could not be determined in
the present study, because of its cross-sec-
tional characteristic. This is a limitation of
the study, which for the same reason did not
sequentially evaluate the serum ferritin
concentration. In spite of such fact, the
present study results indicate that the as-
sessment of hepatic iron overload by means
of MRI in SCA patients submitted to regu-
lar erythrocyte transfusion may be useful to
determining preemptive therapeutic inter-
ventions based on the utilization of iron
chelating agents, with a view on the pres-
ervation of the functions of several organs
and systems.
CONCLUSION
The EHIC obtained by means of MRI
was efficient in the estimation of hepatic
iron overload in SCA patients undergoing
regular red blood cell transfusion regimen.
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